The principal conclusion point was the safety and tolerability of sifalimumab. Therapy-emergent adverse events (AEs) and significant AEs (SAEs) and their severity, end result, and any romance on the review medication ended up recorded via the investigator all through the examine. AEs ended up viewed as very likely to be https://biib02122109.bligblogging.com/31415834/the-fact-about-bcat-in-4-that-no-one-is-suggesting